Publisert 19.12.2018

EPO patent granted December 19th 2018

Granted EPO (European Patent Office) patent in wound healing.


Regenics have recieved notification from the European Patent Office on December 19th 2018 of EPOs granting of granting of a European patent No. 2656832 from EP patent application No. 1217881.5   


The patent granted on December 19, 2018 as EP Patent Number 

2656832. The term of the patent is May 11th, 2027.

Additional info on our other EPO patents: EP 2296676.  09742464.2

For more information, please contact Henrik Lund, CEO

Regenics AS has developed a number of assays and techniques to study effects of various substances on skin cells both in vitroin vivo and in the clinic. Our focus is to develop products and techniques for therapeutic skin applications and to improve skin appearance.